NOVEMBER 2022LIFE SCIENCES REVIEW6The rapidly advancing global healthcare infrastructure and the rise in infectious diseases and outbreaks like COVID have spiked the need for early detection of contagious diseases. The market for clinical microbiology is expected to gain consistent traction in the coming years due to the growing demand for early and accurate disease diagnosis and increasing R&D activities to develop pathogen-specific diagnostic kits. In addition, the growing adoption of advanced genomic techniques for disease detection, increased availability of low-cost clinical microbiology products, and growing use of clinical microbiology products across clinical diagnostic centers and research laboratories are other factors fueling the growth of the global clinical microbiology market.Clinical microbiology aids in the rapid diagnosis of pathogens and ensures the effective administration of antibiotics to enhance treatment results. Technological advancements in disease diagnostics coupled with the emergence of a range of molecular diagnostics techniques aid in the early detection and effective treatment of pathogen-borne diseases. Growing adoption of advanced diagnostic techniques, including next-generation sequencing, real-time PCR, and mass spectrometry coupled with PCR, further aid in the effective identification and characterization of various pathogens. MALDI­TOF mass spectrometry has already made its way as a new diagnostic gold standard method in clinical microbiology for rapid, accurate, and cost-effective microbial species identification.Though the lack of trained professionals and effective training programs, specifically in regions where the burden of infectious diseases is higher, is estimated to hamper the clinical microbiology market. Automation replacing the manually operated conventional platforms might substitute for the lack of trained professionals. Furthermore, the major competitors are concentrating on adopting technology improvements in illness diagnostics, such as the use of machine learning, which aids in the delivery of speedy and accurate results. This, together with the emergence of many molecular diagnostic techniques, is presenting the market with lucrative growth potential. Needless to say, the increasing research and development initiatives to improvise the healthcare infrastructure and the availability of cost-efficient clinical microbiological solutions have become key factors propelling the market growth.Let us know your thoughts.EDITORIALR&D and Healthcare Infrastructure Drives Clinical Microbiology MarketCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com NOVEMBER - 21 - 2022, Vol 03, Issue - 34 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz Clara Matthew
< Page 5 | Page 7 >